Biomimetic MOF Nanoparticles Delivery of C-Dot Nanozyme and CRISPR/Cas9 System for Site-Specific Treatment of Ulcerative Colitis

ACS Appl Mater Interfaces. 2022 Feb 9;14(5):6358-6369. doi: 10.1021/acsami.1c21700. Epub 2022 Jan 31.

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) of unknown etiology affecting the colon and rectum. Previous studies have found that reactive oxygen species (ROS) overproduction and transmembrane glycoprotein CD98 (encoded by SLC3A2) upregulation played important roles in the initiation and progression of UC. On the basis of this, a biomimetic pH-responsive metal organic framework (MOF) carrier was constructed to deliver carbon nanodot-SOD nanozyme and clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) (CRISPR/Cas9) system for site-specific treatment of UC. In this system, carbon nanodots (C-dots) and CD98 CRISPR/Cas9 plasmid were successfully encapsulated into MOF carrier (ZIF-8 nanoparticles) by a one-pot approach (formed as CCZ), and then camouflaged with macrophage membrane (formed as CCZM). It was worth noting that the C-dot nanozyme showed excellent superoxide dismutase (SOD) enzymatic activity, which could scavenge ROS effectively. As expected, this biomimetic system exhibited pH-responsive, immune escape, and inflammation targeting capability simultaneously. In vitro experiments showed that ROS was significantly eliminated, and CD98 was downregulated by CCZM. In the dextran sulfate sodium salt (DSS)-induced UC model, administration of CCZM significantly ameliorated the inflammation symptoms of mice, including the colon length and pathological parameters such as epithelium integrity and inflammation infiltration. In addition, both in vitro and in vivo results demonstrated that biomimetic nanoparticles effectively reduced the expression of pro-inflammatory cytokines. Overall, this study would provide a promising approach for the precise treatment of UC.

Keywords: C-dot nanozyme; CD98; CRISPR/Cas9; ROS; biomimetic MOF; macrophage membrane; ulcerative colitis.

MeSH terms

  • Animals
  • Biomimetic Materials / chemistry*
  • CRISPR-Cas Systems / genetics*
  • Carbon / chemistry
  • Colitis, Ulcerative / chemically induced
  • Colitis, Ulcerative / drug therapy
  • Colon / pathology
  • Dextran Sulfate / toxicity
  • Disease Models, Animal
  • Drug Carriers / chemistry
  • Female
  • Fusion Regulatory Protein-1 / genetics
  • Fusion Regulatory Protein-1 / metabolism
  • Humans
  • Imidazoles / chemistry*
  • Metal-Organic Frameworks / chemistry*
  • Mice
  • Mice, Inbred C57BL
  • Nanoparticles / chemistry*
  • Plasmids / genetics
  • Plasmids / metabolism
  • Quantum Dots / chemistry*
  • Reactive Oxygen Species / metabolism
  • Superoxide Dismutase / chemistry*
  • Superoxide Dismutase / therapeutic use

Substances

  • Drug Carriers
  • Fusion Regulatory Protein-1
  • Imidazoles
  • Metal-Organic Frameworks
  • Reactive Oxygen Species
  • ZIF-8 metal-organic framework
  • Carbon
  • Dextran Sulfate
  • Superoxide Dismutase